Tianjin Zhipu Instruments Completes Tens of Millions RMB Pre-A Funding Round, Spearheading Innovation in Mass Spectrometry Technology

In the field of mass spectrometry, an emerging high-tech enterprise is attracting widespread attention from both within and outside the industry with its innovative strength and rapid growth. Recently,Tianjin Zhipu Instrument Co., Ltd. (hereinafter referred to as “Tianjin Zhipu”) announced the successful completion of its Pre-A financing round, raising tens of millions of yuan. The round was led by Beiyang Haitang Fund, with participation from well-known investors including Haihe Industry Fund, iFlytek Venture Capital, Andon Health, and Binhai Industry Fund.This milestone marks a solid step forward for Tianjin Zhipu on the path to the industrialization of mass spectrometry.

Tianjin Zhipu, originating from the renowned Tianjin University Wang Yan Mass Spectrometry Team, has become a leader in the industrialization of high-end domestically produced mass spectrometry instruments, leveraging over 30 years of technical accumulation and innovation capabilities. The company has consistently strengthened the deep integration of industry, academia, and research. It has not only demonstrated exceptional capability in translating scientific achievements into practical applications in the R&D of multi-dimensional mass spectrometry technologies—including LC-TQ, QTOF MS, ICP-MS, MALDI TOF-MS, PTR-MS, and mass cytometry—but also established a comprehensive supply chain system for domestically produced mass spectrometers through various approaches such as independent core development, platform sharing, and industrial integration.

The funds from this round of financing will be primarily used for the series development of high-end mass spectrometry instruments, the independent R&D of fully automated and intelligent medical mass spectrometry platforms, the integration of mass spectrometry with artificial intelligence technologies, and the market expansion of already launched products. This will not only propel Tianjin Zhipu to achieve further advancements in technological innovation but also help the company realize a qualitative leap in its new commercialization strategy.

Tianjin Zhipu’s development strategy has received unanimous recognition from its investors. With the participation of Beiyang Haitang Fund, the company has not only secured financial support but also gained access to abundant resources and platforms through the fund’s close ties with Tianjin University and the Tiankai Higher Education Innovation Park. This collaboration provides strong endorsement for Tianjin Zhipu’s implementation of its innovative “scientist + entrepreneur + investor” tripartite development model. iFlytek Ventures, as the industrial investment platform of iFlytek, will facilitate in-depth cooperation between iFlytek—a leading enterprise in China’s artificial intelligence sector—and Tianjin Zhipu in integrating mass spectrometry instruments with AI, jointly exploring the boundless possibilities of technological innovation. Furthermore, the involvement of Haihe Industry Fund, Andon Health, and Binhai Industry Fund will provide robust support and application scenario resources for Tianjin Zhipu’s deep collaborative innovations in biopharmaceuticals, precision medicine, and other fields, injecting new momentum into its long-term strategic layout.

Du Kang, Researcher, Founder and CEO of Tianjin ZhipuHe stated, “In the competitive landscape of domestic and international mass spectrometry instrument markets, Tianjin Zhipu must not only achieve breakthroughs in core technologies but also innovate its business model. The participation of investors in this funding round has filled us with confidence for future development. We will continue to strengthen the cross-industry integration and collaborative empowerment of high-end mass spectrometry instruments across various sectors, implement the ‘Mass Spectrometry Plus’ service system, and support technological innovation and the enhancement of new quality productive forces in diverse industries!”

Professor Wang Yan, Chief Scientist at Zhipu Tianjin and Professor at Tianjin UniversityEmphasis: “For many years, the Analytical Instrumentation program at Tianjin University has cultivated and supplied a large number of outstanding talents to domestic and international industry institutions. Tianjin Zhipu, a representative enterprise, not only focuses on the product commercialization and market promotion of proprietary scientific research achievements from university research teams but also actively participates in Tianjin’s initiatives to revitalize the city through science and education and strengthen it with talent. The company is strategically planning future industrial layouts and reinforcing the deep integration of the innovation chain, industrial chain, and talent chain. The Tianjin Biomedical High-End Analytical Testing Equipment Concept Verification Platform, led by the enterprise, is soon to be established in the Tiankai Higher Education Innovation Park. Furthermore, efforts will be made to form the Tianjin Analytical Testing Equipment Innovation Consortium, establish new-type R&D institutions, promote the open sharing of scientific and technological resources, and accelerate the translation of scientific and technological achievements into real productive forces, thereby making greater contributions to scientific and technological innovation and industrial development in Tianjin and across the nation.”

As mass spectrometry technology continues to expand across the fields of analytical chemistry and life sciences, Tianjin Zhipu has earned the trust of a growing number of customers by offering cost-effective mass spectrometry instruments, highly adaptable industry-specific solutions, and a service system tailored to domestic clients. The company is committed to building a first-class Chinese-made mass spectrometry instrument service team, delivering comprehensive mass spectrometry solutions driven by customer needs.

Tianjin Zhipu’s rapid growth and notable achievements undoubtedly present a compelling investment opportunity for future financing institutions, while also showcasing a robust and fast-growing brand image to laboratory instrument users, thereby enhancing market confidence and expectations for the upgrade of domestically produced high-end instruments and equipment.

Tianjin Zhipu Instrument Co., Ltd., established in April 2021, leverages the core R&D team’s extensive experience in mass spectrometry instrument research and manufacturing accumulated through Tianjin University’s Analytical Testing Technology and Instrument Innovation Platform. The company is dedicated to developing and producing high-performance mass spectrometry instruments for the fields of analytical chemistry and life sciences, providing intelligent and automated solutions for clinical diagnostics. Catering to the markets of medical laboratory testing, food and drug chemical analysis, and public safety, the company offers comprehensive solutions featuring scenario-specific mass spectrometry instruments, as well as OEM/ODM services.